MedTrace Logo

Peri Tonsillar Infiltration of Ketamine or Bupivacaine for Post Tonsillectomy Analgesia

NCT05341323 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-07-19

No results posted yet for this study

Summary

Comparison between the analgesic effect of local infiltration of either Bupivacaine or ketamine in the peritonsillar area before the incision of tonsillectomy to achieve postoperative analgesia

Conditions

  • Post Operative Pain

Interventions

DRUG

Ketamine.

Peritonsillar infiltration of ketamine

DRUG

Bupivacaine

peritonsillar infiltration of Bupivacaine

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Osama Elshrief, Professor · Dean of Faculty of Medicine

  • Ibrahem Risk, Professor · Professor of ENT

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-02
Primary Completion
2022-07-02
Completion
2022-07-02

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05341323 on ClinicalTrials.gov